Research article · 2014
Conference abstract
Pneumococcal infections and vaccination
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
P neumococci are major contributors to morbidity and mortality worldwide. They are the major cause of milder respiratory tract infections such as otitis and sinusitis, but also to more severe invasive infections such as community-acquired pneumonia with associated septicemia and meningitis. Even though being a devastating pathogen, pneumococci are also common colonizers of the upper respiratory tract of healthy children where from they may spread to cause disease. Risk groups for acquiring an invasive pneumococcal infection (IPD) include preschool children and the elderly, as well as immunocompromised individuals, splenectomised, and patients with a previous influenza virus infection. Several bacterial virulence factors have been described for pneumococci of which a major one is the capsular polysaccharide. Depending on differences in these capsular structures so far more than 90 different serotypes have been distinguished. Recently so called conjugated vaccines (PCV) have been introduced into the child hood vaccination program in many countries. These vaccines are based on a limited amount (7, 10 or 13) of the capsular serotypes. In Sweden PCVs were introduced in the whole of Sweden year 2009. Vaccine introduction has led to a reduction in the incidence of IPD in vaccinated children but also to serotype replacementand an increase of non-vaccine type disease.
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
The impact of the classical, lectin and alternative pathways of complement activation on protective immunity against Streptococcus pneumonia infection following vaccination with pneumococcal vaccines
Conference abstract
Mucosal immunization with an unadjuvanted vaccine that targets S. pneumoniae PspA to human Fc?RI protects against Pneumococcal infection via complement- and Lactoferrin-Mediated Bactericidal Activity
Research article · 28 Feb 2022
Comparing the Uptake of Seasonal Influenza and Pneumococcal Vaccines among Older Adults in Australia and Hong Kong between 2016 and 2018
Conference abstract · 16 Jul 2021
Pediatric pneumococcal carriage for Jordan: Coverage of old and future pneumococcal conjugate vaccines in the periods 2008-2010 and 2015-2019
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advancing Immune-Based Disease Management through Therapeutic Vaccines
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Birgitta Henriques-Normark”
